WALTER SISULU UNIVERSITY
🇿🇦South Africa
- Country
- 🇿🇦South Africa
- Ownership
- -
- Established
- 2005-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.wsu.ac.za/
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero
- Conditions
- Offspring of Pre-eclamptic Mothers
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- Walter Sisulu University
- Target Recruit Count
- 234
- Registration Number
- NCT05091827
Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in Utero
- Conditions
- In Utero Drug Exposure
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- Walter Sisulu University
- Target Recruit Count
- 320
- Registration Number
- NCT04763668
- Locations
- 🇿🇦
Umtata General Hospital, Mthatha, Eastern Cape, South Africa
News
No news found